Industry News
Antibacterial specialist Stayzon set to expand internationally
Fresche Bioscience has signed an agreement to support manufacture of Stayzon's range of antimicrobial coatings and ancillary treatments. [ + ]
Biotech receives funding for Parkinson's tech, clinical trial
Global Kinetics Corporation has received funding for its work improving the lives of those with Parkinson's disease using advanced medical technologies. [ + ]
Australia and US strike up STEM partnership
Science & Technology Australia and the American Association for the Advancement of Science have pledged to foster collaborations to enhance the role of STEM on the global stage. [ + ]
ReCell saves skin, reduces treatment costs for burn victims
AVITA Medical has conducted a pivotal clinical trial demonstrating the effectiveness of its ReCell Autologous Cell Harvesting Device in the treatment of second-degree burns. [ + ]
Merck named Best Bioprocessing Supplier in Asia
Science and technology company Merck was named the Best Bioprocessing Supplier at the Asia-Pacific Bioprocessing Excellence Awards 2018, held earlier this year. [ + ]
Clinical study commences for brain cancer drug
Kazia Therapeutics' small molecule inhibitor is being developed to treat glioblastoma multiforme — the most common and aggressive form of primary brain cancer. [ + ]
Phospholipid formulation found to relieve PMS
A clinical study has indicated the positive effects of Lipogen PMS, a natural phospholipid formulation, in treating and relieving premenstrual syndrome (PMS) symptoms. [ + ]
Face-matching technology helps diagnose intellectual disability
The Hunter Medical Research Institute has launched a web platform that will help unravel the mysteries behind undiagnosed intellectual disabilities in children. [ + ]
Clinical trials centre adopts unified data management platform
The NHMRC Clinical Trial Centre will use technology company Medidata's unified platform and analytics for all major new studies starting in 2018. [ + ]
How much does cancer cost the Australian economy?
Experiencing cancer is tough for any patient, as well as their family and friends. But it seems that cancer is also not great for the Australian economy. [ + ]
Chris Goodnow appointed as executive director of Garvan
The Garvan Institute of Medical Research has appointed Professor Chris Goodnow as its executive director. [ + ]
Artificial enzymes use light to kill bacteria
Made from tiny nanorods, the newly developed 'NanoZymes' use visible light to create highly reactive oxygen species that rapidly break down and kill bacteria. [ + ]
Optimum treatment for advanced melanoma patients revealed
Researchers now have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain. [ + ]
Want to help trial a vaccine for coeliac disease?
The University of the Sunshine Coast's Clinical Trials Centre has launched a clinical trial of a new vaccine that aims to switch off the immune response to gluten. [ + ]
Medical cannabis conference coming to Sydney
CannaTech AU will highlight industry thought leaders from Australia and around the world who are known for their contributions to the global medical cannabis market. [ + ]
